Delhi: Zydus Cadila has received an emergency use authorization from the Drugs Controller General of India (DGCI) for the use of “Vilafin” to treat moderate COVID-19...
New Delhi: On Friday, the Drugs Controller General of India (DGCI) granted urgent approval to Virafin, an antiviral drug for Zydus Cadila. The drug, pegylated interferon...
On Friday, the Drugs Controller General of India (DCGI) approved the emergency use of Virafin, an antiviral drug from Indian pharmaceutical company Zydus Cadila, for the...
Recent Comments